Literature DB >> 8877857

Primary structure of bovine adenosine deaminase.

M A Kelly1, M M Vestling, C M Murphy, S Hua, T Sumpter, C Fenselau.   

Abstract

Derivatized bovine adenosine deaminase is used in enzyme replacement therapy and as an adjunct to gene therapy against severe combined immunodeficiency syndrome. Although a gene sequence is known for human adenosine deaminase, the structure of the bovine enzyme has not been characterized. Structure studies using mass spectrometry are reported here that evaluate sequence, processing, post-translational modifications and the extent of homology between the human protein and its therapeutic surrogate.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8877857     DOI: 10.1016/0731-7085(96)01845-6

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  3 in total

1.  Effects of substitutions at the 4' and 2 positions on the bioactivity of 4'-ethynyl-2-fluoro-2'-deoxyadenosine.

Authors:  Karen A Kirby; Eleftherios Michailidis; Tracy L Fetterly; Musetta A Steinbach; Kamalendra Singh; Bruno Marchand; Maxwell D Leslie; Ariel N Hagedorn; Eiichi N Kodama; Victor E Marquez; Stephen H Hughes; Hiroaki Mitsuya; Michael A Parniak; Stefan G Sarafianos
Journal:  Antimicrob Agents Chemother       Date:  2013-10-07       Impact factor: 5.191

2.  Expression of a functional human adenosine deaminase in transgenic tobacco plants.

Authors:  Sanjeewa Singhabahu; John George; David Bringloe
Journal:  Transgenic Res       Date:  2012-12-21       Impact factor: 2.788

3.  Development of Adenosine Deaminase-Specific IgY Antibodies: Diagnostic and Inhibitory Application.

Authors:  Agnieszka Łupicka-Słowik; Mateusz Psurski; Renata Grzywa; Kamila Bobrek; Patrycja Smok; Maciej Walczak; Andrzej Gaweł; Tadeusz Stefaniak; Józef Oleksyszyn; Marcin Sieńczyk
Journal:  Appl Biochem Biotechnol       Date:  2017-10-17       Impact factor: 2.926

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.